aTyr Pharma Receives FDA Fast Track Designation for Resolaris™
— First Reported Fast Track Designation for a FSHD Treatment — SAN DIEGO, Oct. 24, 2016 /PRNewswire/ —Â aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and […]